|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
24
|
|
pubmed:dateCreated |
1999-6-17
|
|
pubmed:abstractText |
Patients with implantable cardioverter-defibrillators often receive adjunctive antiarrhythmic therapy to prevent frequent shocks. We tested the efficacy and safety of sotalol, a beta-blocker with class III antiarrhythmic effects, for this purpose.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0028-4793
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
17
|
|
pubmed:volume |
340
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1855-62
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10369848-Adrenergic beta-Antagonists,
pubmed-meshheading:10369848-Adult,
pubmed-meshheading:10369848-Aged,
pubmed-meshheading:10369848-Anti-Arrhythmia Agents,
pubmed-meshheading:10369848-Chemotherapy, Adjuvant,
pubmed-meshheading:10369848-Defibrillators, Implantable,
pubmed-meshheading:10369848-Double-Blind Method,
pubmed-meshheading:10369848-Female,
pubmed-meshheading:10369848-Humans,
pubmed-meshheading:10369848-Male,
pubmed-meshheading:10369848-Middle Aged,
pubmed-meshheading:10369848-Sotalol,
pubmed-meshheading:10369848-Stroke Volume,
pubmed-meshheading:10369848-Survival Analysis,
pubmed-meshheading:10369848-Tachycardia
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group.
|
|
pubmed:affiliation |
Texas Arrhythmia Institute, Houston 77030, USA. apacifico@tmh.tmc.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
